Changes in Health Insurance and Payment for Substance Use Treatment

References

• French MT, Salomé HJ, Krupski A, McKay JR, Donovan DM, McLellan AT, Durell J. Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington. Eval Rev 2000; 24: 609–634
   PubMed Web of Science ®Google Scholar
• Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000; 90: 1100–1111
   PubMed Web of Science ®Google Scholar
• Frank RG, McGuire TG. Estimating costs of mental health and substance abuse coverage. Health Affairs 1995; 14: 102–115
   Web of Science ®Google Scholar
• French MT, Dunlop LJ, Calinis DN, Rachel JU, Zarkin GA. Health care reforms and managed care for substance abuse services: findings from 11 case studies. J Public Health Policy 1996; 17: 181–203
   PubMed Web of Science ®Google Scholar
• Garcia LM, McGeary KA, Shultz JM, McCoy CB. The impact of insurance status on drug abuse treatment completion. J Health Care Finance 1999; 26: 40–47
   PubMedGoogle Scholar
• Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?. J Substance Abuse Treatment 1998; 15: 183–191
   PubMed Web of Science ®Google Scholar
• Shah NG, Celentano DD, Vlahov D, Stambolis V, Johnson L, Nelson KE, Strathdee SA. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-Serostatus. AIDS 2000; 14: 2035–2043
   PubMed Web of Science ®Google Scholar
• Gabel J, Levitt L, Pickreigh J, Whitmore H, Holve E, Hankins S, Miller N. Job-based health insurance in : premiums rise sharply while coverage grows. Health Affairs 2000; 19(2000)144–151
   Google Scholar
• Hollohan J, Kim J. Why does the number of uninsured Americans continue to grow?. J Health Affairs 2000; 19: 188–196
   Google Scholar
• Wise P, Chavkin W, Romero D. Assessing the effects of welfare reform policies on reproductive and infant health. Am J Public Health 1999; 89: 1514–1521
   Web of Science ®Google Scholar
• Zarkin GA, Galinis DN, French MT, Fountain DL, Ingram PW, Guyett VA. Financing strategies for drug abuse treatment programs. J Substance Abuse Treatment 1995; 12: 385–399
   PubMed Web of Science ®Google Scholar
• Ellwood MR, Ku L. Welfare and immigration reforms: unintended side effects for medicaid. Health Affairs 1998; 17: 137–151
   Web of Science ®Google Scholar
• Chavkin W, Romero D, Wise PH. State welfare reform policies and declines in health insurance. Am J Public Health 2000; 90: 900–908
   PubMed Web of Science ®Google Scholar
• Jayakody R, Danziger S, Pollack H. Welfare reform, substance use, and mental health. J Health Politics, Policy Law 2000; 25: 623–651
   PubMed Web of Science ®Google Scholar
• Gresenz CR, Watkins K, Podus D. Supplemental security income (SSI), disability insurance (DI), and substance abusers. Community Mental Health J 1998; 34: 337–350
   PubMed Web of Science ®Google Scholar
• Campbell KM, Speiglman R, Barron N, Finnegan MW, Krupski A. The impact of eliminating the SSI drug addiction and alcoholism (DA&A) category on participation in substance abuse treatment among former DA&A beneficiaries. Abstract Book/Association for Health Services Research. 15, 1998 218 p.
   Google Scholar
• Platt JJ. Vocational rehabilitation of drug abusers. Psychol Bull 1995; 117: 416–433
   PubMed Web of Science ®Google Scholar
• McAuliffe WE. Health care policy issues in the drug abuse treatment field. J Health Politics, Policy Law 1990; 15: 357–385
   PubMed Web of Science ®Google Scholar
• Miller NA. An evaluation of substance misuse treatment providers used by an employee assistance program. Int J Addiction 1992; 27: 533–559
   PubMed Web of Science ®Google Scholar
• Mickus M, Colenda CC, Hogan AJ. Knowledge of mental health benefits and preferences for type of mental health providers among the general public. Psychiatric Services 2000; 51: 199–202
   PubMed Web of Science ®Google Scholar
• Bennett JB, Lehman WE. Workplace substance abuse prevention and help seeking: comparing team-oriented and informational training. J Occupational Health Psychol. 2001; 6: 243–254
   PubMedGoogle Scholar
• US Department of Health and Human Services. National Household Survey on Drug Abuse, Substance Abuse and Mental Health Administration, Office of Applied Studies. Washington, D.C. 1994; 1994
   Google Scholar
• US Department of Health and Human Services. National Household Survey on Drug Abuse, Substance Abuse and Mental Health Administration, Office of Applied Studies. Washington, D.C. 1998; 1998
   Google Scholar
• Shah BV, Barnwell BG, Bieler GS. SUDAAN Users' Manual Release 7.5. Research Triangle Institute: Research Triangle Park, N.C., 1997.
   Google Scholar
• Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med 2001; 76: 410–418
   PubMed Web of Science ®Google Scholar
• Beinecke RH, Goodman M, Lockhart A. The impact of managed care on Massachusetts mental health and substance abuse providers. Admin. Social Work 1997; 21: 41–53
   PubMed Web of Science ®Google Scholar
• Dayhoff DA, Urato CJ, Pope GC. Trends in funding and use of alcohol and drug abuse treatment at specialty facilities, 1990–1994. Am J Public Health 2000; 90: 109–111
   PubMed Web of Science ®Google Scholar
• Shepard DS, Larson MJ, Hodgkin D, Maynard DB. Cost-effectiveness of substance abuse treatment in Ohio. Abstract Book /Association for Health Services Research. 16, 1999; pp. 312–313.
   Google Scholar
• Frank RG, McGuire TG, Bae JP, Rupp A. Solutions for adverse selection in behavioral health care. Health Care Financing Rev 1997; 18: 109–122
   Web of Science ®Google Scholar
• McCaffrey BR. Testimony Before the Senate Judiciary Committee, on the 1998 National Drug Control Strategy, March 4, 1998. Congressional Hearings on Intelligence and Security, Washington, D. C. 1998
   Google Scholar
• Deck DD, McFarland BH. Medicaid managed care and substance abuse treatment. Psychiatric Services 2002; 53: 802
   Google Scholar